Adjuvant therapy for renal-cell carcinoma: settled for now

被引：16
作者：
Duensing, Stefan [1 ,2 ]
Hohenfellner, Markus [2 ]
机构：
[1] Heidelberg Univ, Med Fac Heidelberg, Sect Mol Urooncol, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Med Fac Heidelberg, Dept Urol, D-69120 Heidelberg, Germany
来源：
LANCET | 2016年 / 387卷 / 10032期
关键词：
IMATINIB MESYLATE; INTERFERON; SUNITINIB; ALPHA;
D O I：
10.1016/S0140-6736(16)00653-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1973 / 1974
页数：2
相关论文
共 12 条
[1]   Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma [J].
Capitanio, Umberto ;
Jeldres, Claudio ;
Patard, Jean-Jacques ;
Perrotte, Paul ;
Zini, Laurent ;
de La Taille, Alexandre ;
Ficarra, Vincenzo ;
Cindolo, Luca ;
Bensalah, Karim ;
Artibani, Walter ;
Tostain, Jacques ;
Valeri, Antoine ;
Zigeuner, Richard ;
Mejean, Arnaud ;
Descotes, Jean Luc ;
Lechevallier, Eric ;
Mulders, Peter F. ;
Lang, Herve ;
Jacqmin, Didier ;
Karakiewicz, Pierre I. .
BJU INTERNATIONAL, 2009, 103 (01) :33-37
[2]  
Chin Arnold I, 2006, Rev Urol, V8, P1
[3]   The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors [J].
DeCaprio, James A. ;
Duensing, Anette .
CURRENT OPINION IN ONCOLOGY, 2014, 26 (04) :415-421
[4]   Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial [J].
DeMatteo, Ronald P. ;
Ballman, Karla V. ;
Antonescu, Cristina R. ;
Maki, Robert G. ;
Pisters, Peter W. T. ;
Demetri, George D. ;
Blackstein, Martin E. ;
Blanke, Charles D. ;
von Mehren, Margaret ;
Brennan, Murray F. ;
Patel, Shreyaskumar ;
McCarter, Martin D. ;
Polikoff, Jonathan A. ;
Tan, Benjamin R. ;
Owzar, Kouros .
LANCET, 2009, 373 (9669) :1097-1104
[5]   Sorafenib in advanced clear-cell renal-cell carcinoma [J].
Escudier, Bernard ;
Eisen, Tim ;
Stadler, Walter M. ;
Szczylik, Cezary ;
Oudard, Stephane ;
Siebels, Michael ;
Negrier, Sylvie ;
Chevreau, Christine ;
Solska, Ewa ;
Desai, Apurva A. ;
Rolland, Frederic ;
Demkow, Tomasz ;
Hutson, Thomas E. ;
Gore, Martin ;
Freeman, Scott ;
Schwartz, Brian ;
Shan, Minghua ;
Simantov, Ronit ;
Bukowski, Ronald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134
[6]   Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients [J].
Griffioen, Arjan W. ;
Mans, Laurie A. ;
de Graaf, Annemarie M. A. ;
Nowak-Sliwinska, Patrycja ;
de Hoog, Celine L. M. M. ;
de Jong, Trees A. M. ;
Vyth-Dreese, Florry A. ;
van Beijnum, Judy R. ;
Bex, Axel ;
Jonasch, Eric .
CLINICAL CANCER RESEARCH, 2012, 18 (14) :3961-3971
[7]   Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial [J].
Haas, Naomi B. ;
Manola, Judith ;
Uzzo, Robert G. ;
Flaherty, Keith T. ;
Wood, Christopher G. ;
Kane, Christopher ;
Jewett, Michael ;
Dutcher, Janice P. ;
Atkins, Michael B. ;
Pins, Michael ;
Wilding, George ;
Cella, David ;
Wagner, Lynne ;
Matin, Surena ;
Kuzel, Timothy M. ;
Sexton, Wade J. ;
Wong, Yu-Ning ;
Choueiri, Toni K. ;
Pili, Roberto ;
Puzanov, Igor ;
Kohli, Manish ;
Stadler, Walter ;
Carducci, Michael ;
Coomes, Robert ;
DiPaola, Robert S. .
LANCET, 2016, 387 (10032) :2008-2016
[8]   Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].
Hanahan, D ;
Folkman, J .
CELL, 1996, 86 (03) :353-364
[9]   Lymphatogenous spread of renal cell carcinoma: An autopsy study [J].
Johnsen, JA ;
Hellsten, S .
JOURNAL OF UROLOGY, 1997, 157 (02) :450-453
[10]   Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [J].
Motzer, Robert J. ;
Hutson, Thomas E. ;
Tomczak, Piotr ;
Michaelson, M. Dror ;
Bukowski, Ronald M. ;
Rixe, Olivier ;
Oudard, Stephane ;
Negrier, Sylvie ;
Szczylik, Cezary ;
Kim, Sindy T. ;
Chen, Isan ;
Bycott, Paul W. ;
Baum, Charles M. ;
Figlin, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :115-124
12